Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of SGLT2 Inhibitors on Cardioprotection in Patients Undergoing Heart Transplantation

NCT06147271 is registered in ClinicalTrials.gov with Universidade Federal do Ceara as lead sponsor.

NCT NCT06147271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06147271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of SGLT2 Inhibitors on Cardioprotection in Patients Undergoing Heart Transplantation
Lead sponsor
Universidade Federal do Ceara
Phase
Phase 2
Overall status
Unknown status
Start date
November 20, 2023
Completion date
August 1, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy, rejection heart transplant, transplant; failure, heart